Une étude publiée en juin 2026 dans Nature Medicine avance une explication originale à l’augmentation des cancers chez les jeunes : les jeunes générations vieilliraient plus vite de l’intérieur.
Cancer
La majorité des femmes traitées pour un cancer du sein se plaignent de troubles – plus ou moins transitoires – de la mémoire, de l’attention ou sentent que leur cerveau fonctionne moins bien ou moins vite. Est-il possible d’agir sur cet effet secondaire du traitement du cancer ? Voici ce que disent les études.
Les patients traités pour un cancer rapportent souvent des symptômes cognitifs appelés « troubles cognitifs liés au cancer » (Cancer-related cognitive impairment ou CRCI en anglais) tels que des problèmes de mémoire à court terme, de mémoire de travail, d’attention, de fonction exécutives...
- Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014). Prevalence, mechanisms, and management of cancer-related cognitive impairment. International review of psychiatry (Abingdon, England), 26(1), 102–113.
- Yang Y, Hendrix CC. Cancer-Related Cognitive Impairment in Breast Cancer Patients: Influences of Psychological Variables. Asia Pac J Oncol Nurs. 2018;5(3):296-306. doi:10.4103/apjon.apjon_16_18.
- Dhillon HM, Tannock IF, Pond GR, Renton C, Rourke SB, Vardy JL. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy. J Cancer Surviv. 2018;12(2):178-185.
- Collins, B., MacKenzie, J., Tasca, G., Scherling, C., & Smith, A. (2014). Persistent Cognitive Changes in Breast Cancer Patients 1 Year Following Completion of Chemotherapy. Journal of the International Neuropsychological Society, 20(4), 370-379.
- Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T. A metaanalysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev 2013; 39(3): 297–304.
- Ganz PA, Kwan L, Castellon SA, et al. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst. 2013;105(11):791-801. doi:10.1093/jnci/djt073.
- Amidi A, Christensen S, Mehlsen M, Jensen AB, Pedersen AD, Zachariae R. Long-term subjective cognitive functioning following adjuvant systemic treatment: 7-9 years follow-up of a nationwide cohort of women treated for primary breast cancer. Br J Cancer. 2015;113(5):794-801.
- Winocur G, Henkelman M, Wojtowicz JM, Zhang H, Binns MA, Tannock IF. The effects of chemotherapy on cognitive function in a mouse model: a prospective study. Clin Cancer Res. 2012;18(11):3112-3121.
- Fardell JE, Vardy J, Monds LA, Johnston IN. The long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy.Behav Brain Res 2015; 291: 80–88.
- Dubois M, Lapinte N, Villier V, et al. Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: role of glucose as adjuvant. Neuropharmacology. 2014;79:234-248.
- Christie LA, Acharya MM, Parihar VK et al. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res 2012; 18(7): 1954–1965.
- Lomeli N, Di K, Czerniawski J et al. Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radic Biol Med 2017; 102: 274–286.
- Lange, M., Heutte, N., Rigal, O., Noal, S., Kurtz, J. E., Lévy, C., Allouache, D., Rieux, C., Lefel, J., Clarisse, B., Veyret, C., Barthélémy, P., Longato, N., Castel, H., Eustache, F., Giffard, B., & Joly, F. (2016). Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment. The oncologist, 21(11), 1337–1348.
- Lange M, Joly F, Vardy J, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. 2019;30(12):1925-1940.
- Lange M, Licaj I, Clarisse B et al. Cognitive complaints in cancer survivors and expectations for support: results from a web-based survey. Cancer Med 2019; 8(5): 2654–2663.
- Karschnia P, Parsons MW, Dietrich J. Pharmacologic management of cognitive impairment induced by cancer therapy. Lancet Oncol 2019; 20(2): e92–e102.
- Lyons L, ElBeltagy M, Bennett G, Wigmore P. Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery. PLoS One 2012; 7(1): e30010.
- Janelsins, M. C., Peppone, L. J., Heckler, C. E., Kesler, S. R., Sprod, L. K., Atkins, J., Melnik, M., Kamen, C., Giguere, J., Messino, M. J., Mohile, S. G., & Mustian, K. M. (2016). YOCAS©® Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial: Investigating Relationships Between Memory and Sleep. Integrative cancer therapies, 15(3), 263–271.
- Winocur, G., Wojtowicz, J.M., Huang, J. et al. Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats. Psychopharmacology 231, 2311–2320 (2014).
- Oh B, Butow PN, Mullan BA, et al. Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Support Care Cancer. 2012;20(6):1235-1242.
- Reid-Arndt SA, Matsuda S, Cox CR. Tai Chi effects on neuropsychological, emotional, and physical functioning following cancer treatment: a pilot study. Complement Ther Clin Pract. 2012;18(1):26-30.
- Ercoli LM, Petersen L, Hunter AM et al. Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial. Psychooncology 2015; 24(11): 1360–1367.
- Bray VJ, Dhillon HM, Bell ML et al. Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy. J Clin Oncol 2017; 35(2): 217–225.
- Von AD, Carpenter JS, Saykin A et al. Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat 2012; 135: 799–809.
- Kesler S, Hadi Hosseini SM, Heckler C et al. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer 2013; 13(4): 299–306.
- Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005;12(4):278-285.
- Carlson LE, Speca M, Faris P, Patel KD. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun. 2007;21(8):1038-1049.
- Kelly A. Biegler, M. Alejandro Chaoul & Lorenzo Cohen (2009) Cancer, cognitive impairment, and meditation, Acta Oncologica, 48:1, 18-26.
- Johns, S.A., Von Ah, D., Brown, L.F. et al. Randomized controlled pilot trial of mindfulness-based stress reduction for breast and colorectal cancer survivors: effects on cancer-related cognitive impairment. J Cancer Surviv 10, 437–448 (2016).
- Ashley M. Henneghan,Heather Becker,Michelle L. Harrison,Kelly Inselmann,Brandon Fico,Helen Schafer,Elizabeth King,Debra Patt,Shelli Kesler : A Randomized Control Trial of Meditation Compared to Music Listening to Improve Cognitive Function for Breast Cancer Survivors: Feasibility and Acceptability. Complementary Therapies in Clinical Practice, Volume 41, November 2020, 101228.
- Coro, D., Hutchinson, A., Dahlenburg, S. et al. The relationship between diet and cognitive function in adult cancer survivors: a systematic review. J Cancer Surviv 13, 773–791 (2019).
- Zuniga, K.E.; Moran, N.E. Low Serum Carotenoids Are Associated with Self-Reported Cognitive Dysfunction and Inflammatory Markers in Breast Cancer Survivors. Nutrients 2018, 10, 1111.
- Orchard TS, Gaudier-Diaz MM, Weinhold KR, Courtney DeVries A. Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits. Breast Cancer Res Treat. 2017;161(3):391-398.
- Version actuelle le 08/09/2022
- le 02/09/2022
- le 16/10/2020
- le 13/10/2020
Cet article est réservé aux abonnés
Déjà abonné ?
Retrouvez la suite de votre article en vous connectant à votre espace personnel.
Je m'identifie
Pas encore abonné ?
Accédez à des articles et conseils exclusifs en vous abonnant pour seulement 39 € / an.
Je m'abonne Publicité
